Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinical Trial Enrollment

Bristol-Myers Squibb (BMS) building

BMS pulls IDO inhibitor trials as Incyte-prompted rout gathers pace

Suspends enrolment in BMS-986205 trials for NSCLC and head and neck cancer

- PMLiVE

Lucid Group Appoints a New HR Business Partner

Carol Daniel joins Lucid as their new HR Business Partner. Carol will work closely with the managing directors from each of the Lucid Group companies to lead the people plan...

Lucid Group Communications Limited

- PMLiVE

Frontera launch new mHealth offering

Stikke will utilise mobile phones to support patient behaviour

Neurimmune appoints chief business officer

Fabian Buller will further drive the biopharma’s growth strategy

How will new data protection law affect pharma?

Sarah Eglington, of Wilmington Healthcare, explores how GDPR will change pharma’s relationship with healthcare professionals

Wilmington Healthcare

Rules of engagement

Critical points to consider when developing the right content marketing strategy

Barber shops provide a short cut to BP reduction

As well as a haircut, barbers can shave millimetres off men's blood pressure

Life Healthcare Communications

- PMLiVE

Morning brief: Gilead partners with Verily, Roche expands 4DMT partnership and more

A rapid round up of pharma, biotech and healthcare news

Gilead Sciences

Gilead and Verily team up to map inflammatory diseases

Computational analysis could provide deeper understanding of disease

Sanofi reception

Sanofi’s latecomer PD-1 gets date for FDA verdict

While Keytruda extends its lead, Sanofi makes a late bid to enter PD-1 space

- PMLiVE

Elizabeth Egan joins Havas Lynx

She joins as the agency’s new managing director

ProPharma selects new CEO and president

Dawn Sherman takes up the roles effective 14 May

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links